The major changes seen with TPV/Δ66R/mIL-2-treated samples compared to RC is that the capsule increased in thickness and had more immune cells infiltrating the capsule as well as the tumor body, likely due to the adaptive immune system activation following interleukin-2 signaling. This evidence concerns the gene IL2 and neoplasm.